Table 3.
Comparisons of Patient Characteristics Between CR and NR
| CR Pts (n = 35) | NR Pts (n = 21) | p Value | |
|---|---|---|---|
| Median age (years, range) at diagnosis | 73 (70–83) | 73 (70–87) | 0.50 |
| Median WBC count (× 109/L, range) at AML diagnosis | 8.0 (1.2–126.8) | 9.5 (0.8–293.3) | 0.66 |
| Median (%, range) blasts at AML diagnosis | 51 (21–96) | 30.5 (20–67) | 0.76 |
| Median hemoglobin (g/dl, range) at AML diagnosis | 9.1 (7.8–13.9) | 9.45 (7.5–12.0) | 0.42 |
| Median platelet count (× 109/L, range) at AML diagnosis | 64 (16–263) | 51.5 (3–163) | 0.09 |
| Median LDH (range) at AML diagnosis | 539 (113–4734) | 631 (119–3,008) | 0.90 |
| Median total bilirubin (range) at AML diagnosis | 0.7 (0.2–1.4) | 0.4 (0.1–1.8) | 0.67 |
| Median creatinine (range) at AML diagnosis | 0.95 (0.6–2.1) | 1.1 (0.6–1.9) | 0.11 |
CR, complete remission; NR, patients not responsive to induction chemotherapy.